Chem Shift validation: AVS_full
BMRB Entry DOI: doi:10.13018/BMR19935
NMR-STAR file interactive viewer.
NMR-STAR v3 text file.
XML gzip file.
RDF gzip file.
All files associated with the entry
Citation: Tokunaga, Yuji; Takeuchi, Koh; Takahashi, Hideo; Shimada, Ichio. "Allosteric enhancement of MAP kinase p38a's activity and substrate selectivity by docking interactions." Nat. Struct. Mol. Biol. 21, 704-711 (2014).
PubMed: 25038803
Assembly members:
Dual-phosphorylated_human_p38_alpha, polymer, 367 residues, Formula weight is not available
ADENOSINE-5'-DIPHOSPHATE, non-polymer, 427.201 Da.
Natural source: Common Name: human Taxonomy ID: 9606 Superkingdom: Eukaryota Kingdom: Metazoa Genus/species: Homo sapiens
Experimental source: Production method: recombinant technology Host organism: Escherichia coli Vector: pET15b
Entity Sequences (FASTA):
Dual-phosphorylated_human_p38_alpha: MAHHHHHHSQERPTFYRQEL
NKTIWEVPERYQNLSPVGSG
AYGSVCAAFDTKTGLRVAVK
KLSRPFQSIIHAKRTYRELR
LLKHMKHENVIGLLDVFTPA
RSLEEFNDVYLVTHLMGADL
NNIVKCQKLTDDHVQFLIYQ
ILRGLKYIHSADIIHRDLKP
SNLAVNEDCELKILDFGLAR
HTDDEMXGXVATRWYRAPEI
MLNWMHYNQTVDIWSVGCIM
AELLTGRTLFPGTDHIDQLK
LILRLVGTPGAELLKKISSE
SARNYIQSLTQMPKMNFANV
FIGANPLAVDLLEKMLVLDS
DKRITAAQALAHAYFAQYHD
PDDEPVADPYDQSFESRDLL
IDEWKSLTYDEVISFVPPPL
DQEEMES
Data type | Count |
1H chemical shifts | 378 |
13C chemical shifts | 126 |
Entity Assembly ID | Entity Name | Entity ID |
---|---|---|
1 | dual-phosphorylated human p38 alpha (apo) | 1 |
2 | ADP | 2 |
Entity 1, dual-phosphorylated human p38 alpha (apo) 367 residues - Formula weight is not available
Residues 2-8 represent a non-native affinity tag. Thr-180 and Tyr-182 in native sequence are phosphorylated.
1 | MET | ALA | HIS | HIS | HIS | HIS | HIS | HIS | SER | GLN | ||||
2 | GLU | ARG | PRO | THR | PHE | TYR | ARG | GLN | GLU | LEU | ||||
3 | ASN | LYS | THR | ILE | TRP | GLU | VAL | PRO | GLU | ARG | ||||
4 | TYR | GLN | ASN | LEU | SER | PRO | VAL | GLY | SER | GLY | ||||
5 | ALA | TYR | GLY | SER | VAL | CYS | ALA | ALA | PHE | ASP | ||||
6 | THR | LYS | THR | GLY | LEU | ARG | VAL | ALA | VAL | LYS | ||||
7 | LYS | LEU | SER | ARG | PRO | PHE | GLN | SER | ILE | ILE | ||||
8 | HIS | ALA | LYS | ARG | THR | TYR | ARG | GLU | LEU | ARG | ||||
9 | LEU | LEU | LYS | HIS | MET | LYS | HIS | GLU | ASN | VAL | ||||
10 | ILE | GLY | LEU | LEU | ASP | VAL | PHE | THR | PRO | ALA | ||||
11 | ARG | SER | LEU | GLU | GLU | PHE | ASN | ASP | VAL | TYR | ||||
12 | LEU | VAL | THR | HIS | LEU | MET | GLY | ALA | ASP | LEU | ||||
13 | ASN | ASN | ILE | VAL | LYS | CYS | GLN | LYS | LEU | THR | ||||
14 | ASP | ASP | HIS | VAL | GLN | PHE | LEU | ILE | TYR | GLN | ||||
15 | ILE | LEU | ARG | GLY | LEU | LYS | TYR | ILE | HIS | SER | ||||
16 | ALA | ASP | ILE | ILE | HIS | ARG | ASP | LEU | LYS | PRO | ||||
17 | SER | ASN | LEU | ALA | VAL | ASN | GLU | ASP | CYS | GLU | ||||
18 | LEU | LYS | ILE | LEU | ASP | PHE | GLY | LEU | ALA | ARG | ||||
19 | HIS | THR | ASP | ASP | GLU | MET | TPO | GLY | PTR | VAL | ||||
20 | ALA | THR | ARG | TRP | TYR | ARG | ALA | PRO | GLU | ILE | ||||
21 | MET | LEU | ASN | TRP | MET | HIS | TYR | ASN | GLN | THR | ||||
22 | VAL | ASP | ILE | TRP | SER | VAL | GLY | CYS | ILE | MET | ||||
23 | ALA | GLU | LEU | LEU | THR | GLY | ARG | THR | LEU | PHE | ||||
24 | PRO | GLY | THR | ASP | HIS | ILE | ASP | GLN | LEU | LYS | ||||
25 | LEU | ILE | LEU | ARG | LEU | VAL | GLY | THR | PRO | GLY | ||||
26 | ALA | GLU | LEU | LEU | LYS | LYS | ILE | SER | SER | GLU | ||||
27 | SER | ALA | ARG | ASN | TYR | ILE | GLN | SER | LEU | THR | ||||
28 | GLN | MET | PRO | LYS | MET | ASN | PHE | ALA | ASN | VAL | ||||
29 | PHE | ILE | GLY | ALA | ASN | PRO | LEU | ALA | VAL | ASP | ||||
30 | LEU | LEU | GLU | LYS | MET | LEU | VAL | LEU | ASP | SER | ||||
31 | ASP | LYS | ARG | ILE | THR | ALA | ALA | GLN | ALA | LEU | ||||
32 | ALA | HIS | ALA | TYR | PHE | ALA | GLN | TYR | HIS | ASP | ||||
33 | PRO | ASP | ASP | GLU | PRO | VAL | ALA | ASP | PRO | TYR | ||||
34 | ASP | GLN | SER | PHE | GLU | SER | ARG | ASP | LEU | LEU | ||||
35 | ILE | ASP | GLU | TRP | LYS | SER | LEU | THR | TYR | ASP | ||||
36 | GLU | VAL | ILE | SER | PHE | VAL | PRO | PRO | PRO | LEU | ||||
37 | ASP | GLN | GLU | GLU | MET | GLU | SER |
Entity 2, ADP - 427.201 Da.
1 | ADP |
sample_3: dual-phosphorylated human p38 alpha (apo), U-2H15N13C, ILVM-methyl-1H13C], 0.2 mM; TRIS, [U-100% 2H], 25 mM; potassium chloride 150 mM; DTT, [U-2H], 5 mM; ADP 5 mM; H2O 90%; D2O, [U-100% 2H], 10%
sample_conditions_1: temperature: 298 K; pH: 7.5; pressure: 1 atm; ionic strength: 150 mM
Name | Sample | Sample state | Sample conditions |
---|---|---|---|
(H)CC(CO)NH | sample_3 | isotropic | sample_conditions_1 |
H(CCCO)NH | sample_3 | isotropic | sample_conditions_1 |
HCCH-TOCSY | sample_3 | isotropic | sample_conditions_1 |
3D 1H-13C NOESY aliphatic | sample_3 | isotropic | sample_conditions_1 |
TOPSPIN, Bruker Biospin - processing
SPARKY, Goddard - chemical shift assignment
CARA, Keller, R. - chemical shift assignment
BMRB | 17471 17940 19930 19934 19936 19937 |
PDB | |
DBJ | BAB85654 BAE21782 BAE30324 BAE31659 BAF84398 |
EMBL | CAG38743 |
GB | AAA20888 AAA57456 AAA74301 AAB51285 AAC36131 |
PRF | 2111247A 2124426A |
REF | NP_001003206 NP_001136366 NP_001161985 NP_001161986 NP_036081 |
SP | O02812 P47811 P70618 Q16539 |
AlphaFold | O02812 P47811 P70618 Q16539 |